UR-144

CAS No. 1199943-44-6

UR-144 ( UR 144;UR144 )

Catalog No. M10716 CAS No. 1199943-44-6

A potent, selective full agonist of the peripheral cannabinoid receptor CB2 with Ki of 1.8 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    UR-144
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective full agonist of the peripheral cannabinoid receptor CB2 with Ki of 1.8 nM.
  • Description
    A potent, selective full agonist of the peripheral cannabinoid receptor CB2 with Ki of 1.8 nM, >80-fold selectivity over CB2 (Ki=150 nM); possesses an EC50 of 421 nM for human CB1 receptors, and 72 nM for human CB2 receptors, produces bradycardia and hypothermia in rats at a dose of 10 mg/kg.
  • Synonyms
    UR 144;UR144
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1199943-44-6
  • Formula Weight
    311.46
  • Molecular Formula
    C21H29NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCn1cc(c2c1cccc2)C(=O)C3C(C3(C)C)(C)C
  • Chemical Name
    (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Banister SD, et al. ACS Chem Neurosci. 2015 Aug 19;6(8):1445-58.
2. Dhopeshwarkar A, et al. J Pharmacol Exp Ther. 2016 Aug;358(2):342-51.
molnova catalog
related products
  • CP-724714(b)

    CP-724714 is an effective and selective HER2/ErbB2 inhibitor (IC50: 10 nM), >640-fold selectivity against EGFR, Abl, InsR, PDGFR, IRG-1R, Src, VEGFR2, c-Met etc.

  • COR659

    COR659 is a 2-acylaminothiophene derivative able to suppress alcohol and chocolate self-administration in rats, likely via positive allosteric modulation of the GABAB receptor and antagonism/inverse agonism at the cannabinoid CB1 receptor.

  • JD-5037

    A selective, peripherally restricted cannabinoid-1(CB1) receptor blocker with IC50 of 1.5 nM.